حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Kalbe Farma Tbk PT ADR
PTKFYPT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Address: Gedung KALBE, Jakarta, Indonesia, 10510
Analytics
سعر الهدف في وول ستريت
–نسبة السعر إلى الأرباح
26.5765العائد الربحي
2.05 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية PTKFY
تحليلات الأرباح PTKFY
نمو الأرباح على مدى 5 سنوات
41 %النمو المستمر
3 سنينمعدل الدفع 5 سنوات في المتوسط
7234 %تاريخ الأرباح PTKFY
تقييم الأسهم PTKFY
المالية PTKFY
نتائج | 2019 | ديناميات |